APRIL OATTS: Open Payments
NPI 1679197321 · ROSEDALE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$588 in 30 payments from 9 companies in 2025. Trend: 2023 $73 · 2024 $62 · 2025 $588
Food & beverage: $588
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $171 |
| Lilly USA, LLC | 6 | $131 |
| AstraZeneca Pharmaceuticals LP | 4 | $77 |
| PFIZER INC. | 3 | $51 |
| Cranial Technologies, Inc | 3 | $50 |
| Exact Sciences Corporation | 2 | $40 |
| Merck Sharp & Dohme LLC | 2 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: MOUNJARO, Rybelsus, Wegovy, Doc Band, Ozempic, JARDIANCE, BREZTRI, Cologuard Collection Kit.
Industry payments across MD — which companies pay providers there.
